Global Blood Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deep Track Capital, LP(0%),Deep Track Biotechnology Master Fund, Ltd.(0%), etc.
Feb 14, 2023 21:34
Global Blood Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(0.410%),Abigail P. Johnson(0.410%)
Feb 9, 2023 23:59
Global Blood Therapeutics | 15-12G: Notice of termination of registration of a class of securities under Section 12(g) (and amendment thereto)
Oct 17, 2022 20:32
Global Blood Therapeutics | 4: Statement of changes in beneficial ownership of securities
Oct 7, 2022 04:21
Global Blood Therapeutics | 4: Statement of changes in beneficial ownership of securities
Oct 7, 2022 04:20
Global Blood Therapeutics | 4: Statement of changes in beneficial ownership of securities
Oct 7, 2022 04:20
Global Blood Therapeutics | 4: Statement of changes in beneficial ownership of securities
Oct 7, 2022 04:20
Global Blood Therapeutics | 4: Statement of changes in beneficial ownership of securities
Oct 7, 2022 04:20
Global Blood Therapeutics | 4: Statement of changes in beneficial ownership of securities
Oct 7, 2022 04:20
Global Blood Therapeutics | 4: Statement of changes in beneficial ownership of securities
Oct 7, 2022 04:20
Global Blood Therapeutics | 4: Statement of changes in beneficial ownership of securities
Oct 7, 2022 04:20
Global Blood Therapeutics | 4: Statement of changes in beneficial ownership of securities
Oct 7, 2022 04:15
Global Blood Therapeutics | 4: Statement of changes in beneficial ownership of securities
Oct 7, 2022 04:15
Global Blood Therapeutics | 4: Statement of changes in beneficial ownership of securities
Oct 7, 2022 04:15
Global Blood Therapeutics | 4: Statement of changes in beneficial ownership of securities
Oct 7, 2022 04:15
Global Blood Therapeutics | 4: Statement of changes in beneficial ownership of securities
Oct 7, 2022 04:15
Global Blood Therapeutics | 4: Statement of changes in beneficial ownership of securities
Oct 7, 2022 04:15
Global Blood Therapeutics | 4: Statement of changes in beneficial ownership of securities
Oct 7, 2022 04:15
Global Blood Therapeutics | 4: Statement of changes in beneficial ownership of securities
Oct 7, 2022 04:15
Global Blood Therapeutics | S-8 POS: S-8 POS
Oct 6, 2022 04:41
No Data
No Data